Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
BMEA Biomea Fusion
- 3.875
- -0.765-16.49%
Close Dec 18 16:00 ET
- 3.770
- -0.105-2.71%
Pre 06:23 ET
140.42MMarket Cap-0.97P/E (TTM)
4.620High3.810Low2.55MVolume4.620Open4.640Pre Close10.53MTurnover11.34%Turnover RatioLossP/E (Static)36.24MShares20.21052wk High1.85P/B87.01MFloat Cap3.61052wk Low--Dividend TTM22.46MShs Float43.690Historical High--Div YieldTTM17.46%Amplitude2.840Historical Low4.135Avg Price1Lot Size
About Biomea Fusion Company
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.
Company Profile
SymbolBMEA
Company NameBiomea Fusion
Listing DateApr 16, 2021
Issue Price17.00
Founded2017
CEOMr. Thomas Andrew Butler
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address900 Middlefield Road,4th Floor
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-980-9099
Websitehttp://biomeafusion.com
Company Executives
- Name
- Position
- Salary
- Thomas Andrew Butler
- Chief Executive Officer and Chairman of the Board
- 2.71M
- Franco Valle
- Chief Financial Officer and Principal Accounting Officer
- 1.30M
- Dr. Juan Pablo Frias, M.D.
- Chief Medical Officer
- 3.93M
- Rainer M. Erdtmann
- President, Chief Operating Officer and Director
- --
- Dr. Michael J. M. Hitchcock, PhD
- Independent Director
- 241.30K
- Sumita Ray, J.D.
- Independent Director
- 235.30K
- Dr. Eric Aguiar, M.D.
- Independent Director
- 254.80K
- Bihua Chen
- Independent Director
- 228.80K
- Dr. Elizabeth Faust, PhD
- Independent Director
- 221.99K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.